Friday, August 3, 2012

Takeda gains exclusive distributorship for seven OTC products from Johnson and Johnson (JNJ) consumer health portfolio

Takeda and JNJ have signed an agreement  for the exclusive distribution right in Japan of seven OTC brands currently marketed by Johnson & Johnson. Between Takeda and Johnson & Johnson, there already exists an agreement under which Takeda holds the exclusive distribution right in Japan of Nicorette®, a non-prescription (OTC) smoking cessation aid.  Takeda will start the promotion of the  seven  OTC brands by the end of calendar year 2012.  These Seven OTC brands: Aneton®, antitussive/expectorant and treatment rhinitis; Tylenol®, antipyretic/analgesic; COR-TYZINE®, rhinitis rtreatment; Visine®, eye drops; and Terres® Hi, Terra-Cortril®, and Terramycin®, dermatological preparations.

There will be no upfront payment in connection with the Agreement, and there is no modification to Takeda’s consolidated earnings forecasts for fiscal 2012.

Source - Takeda